flucytosine has been researched along with Opportunistic Infections in 47 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 9.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 5.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "A case of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) associated with pulmonary cryptococcosis which was successfully treated with fluconazole (FCZ) and flucytosine (5-FC) is described." | 4.78 | [A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan]. ( Kano, S; Minato, N; Saito, K; Saito, T; Saku, N; Sato, M; Suzuki, N; Takeda, A, 1993) |
| "We present six cases of fusariosis caused by Fusarium solani that were diagnosed over a three-year period in 166 adult patients undergoing chemotherapy for acute leukemia." | 4.77 | Diagnosis and successful treatment of fusariosis in the compromised host. ( Hoagland, M; Hood, AF; Jett-Goheen, M; Junkins, JM; Karp, JE; Merz, WG, 1988) |
| " Flucytosine (5FC) has shown synergistic effect with AmB for treatment of some fungal infections, such as cryptococcosis, but again, its price is a limitation for its use in many regions." | 3.96 | Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and ( Agreda-Mellon, D; de Oliveira, HC; García-Cambero, JP; Lucio, J; Mendes-Giannini, MJS; Rossi, SA; Zaragoza, O, 2020) |
| "We report two cases of cryptococcosis in patients with Waldenstrom's macroglobulinaemia and chronic lymphocytic leukaemia that responded to prolonged therapy with systemic amphotericin and flucytosine." | 3.70 | Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders. ( Colbridge, M; Keenan, F; Melzer, M; Ong, EL; Stainsby, D, 1998) |
| "We report the treatment of cerebral aspergillosis with amphotericin B, flucytosine, surgery, and liposomal amphotericin B (L-AmB) after a liver transplant." | 3.68 | Treatment of cerebral aspergillosis after liver transplantation. ( Berciano, J; Casafont, F; Fábrega, E; Fariñas, MC; Polo, JM; Salesa, R; Vázquez, A, 1992) |
| "Hydrocephalus is the most common neurosurgical complication of cerebral cryptococcosis." | 2.38 | [Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients]. ( Donnet, A; Durand, JM; Graziani, N; Grisoli, F; Harlé, JR; Touta, A, 1993) |
| "This aplastic anemia failed to respond first to an antithymocyte globulin and steroid treatment and then to cyclosporine A." | 2.38 | Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review. ( Bergerat, JP; Dufour, P; Herbrecht, R; Koenig, H; Liu, KL; Maloisel, F; Marcellin, L; Oberling, F; Waller, J; Weber, JC, 1991) |
| "Systemic candidiasis is a disease of increasing incidence and proportions, which appears to be associated with the advances in modern medicine." | 2.38 | Systemic candidiasis. ( Ray, TL, 1989) |
| "A 60-year-old man with acute myeloid leukemia (AML) presented with multifocal muscle abscesses of the legs." | 1.51 | Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report. ( Li, L; Yang, M; Yang, X; Yi, P; Zhang, Y, 2019) |
| "Cryptococcal meningitis is a critical illness affecting 0." | 1.48 | Favorable Evolution of Cryptococcal Meningitis in the Context of Flucytosine Resistance. ( Bedouch, P; Brion, JP; Camara, B; Claustre, J; Pison, C; Quétant, S, 2018) |
| " Clinical improvement was apparent for 13 months during steroid therapy until the slow taper reached a dosage of 20 mg/day." | 1.31 | Cryptococcal infection in sarcoidosis. ( Gibson, LE; Kist, JM; Mehrany, K, 2002) |
| "Mucormycosis is an opportunistic infection occurring in the severely immunocompromised patient." | 1.30 | Successful cure of an extensive burn injury complicated with mucor wound sepsis. ( Tang, D; Wang, W, 1998) |
| "Cryptococcosis is more frequently observed since the appearance of the acquired immunodeficiency syndrome (AIDS)." | 1.28 | [Cryptococcosis: presentation of 26 cases]. ( Azón, A; Gatell, JM; González-Clemente, JM; Mallolas, J; Mensa, J; Miró, JM; Moreno, A; Pedrol, E; Soriano, E, 1992) |
| "Patients with AIDS were younger and predominantly male; they had a shorter duration of prior illness, higher initial serum cryptococcal antigen titers, and lower initial cerebrospinal fluid white blood cell counts than those with neoplastic disease." | 1.28 | Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. ( Armstrong, D; Blevins, A; Cirrincione, C; White, M, 1992) |
| "Fluconazole has shown effectiveness in maintenance therapy, being not be possible to evaluate it as an acute phase therapy because the low number of cases in which it was studied." | 1.28 | [Cryptococcosis in AIDS patients: a study of 19 cases]. ( Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J, 1992) |
| " Because amphotericin B nephrotoxicity was suspected, further intravenous administration was stopped after a cumulative dosage of 2 g." | 1.28 | [Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole]. ( Glück, T; Weber, P; Wiedmann, KH, 1991) |
| "Treatment with amphotericin B, flucytosine and high doses of fluconazole was followed by clinical improvement, although CSF pleocytosis remained." | 1.28 | First report of chronic meningitis caused by Trichosporon beigelii. ( Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G, 1990) |
| "Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases." | 1.28 | Cryptococcosis in AIDS patients: observations concerning CNS involvement. ( de Matos-Marques, B; Pohle, HD; Rögler, G; Seibold, M; Sixt, C; Staib, F; Weinke, T, 1989) |
| "Treatment with amphotericin B, 5-fluorocytosine, and splenectomy proved successful." | 1.27 | Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement. ( Bhansali, S; Crane, L; Karanes, C; Kiel, R; Palutke, W; Ratanatharathorn, V, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (21.28) | 18.7374 |
| 1990's | 23 (48.94) | 18.2507 |
| 2000's | 8 (17.02) | 29.6817 |
| 2010's | 3 (6.38) | 24.3611 |
| 2020's | 3 (6.38) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, K | 1 |
| Tavakoli, S | 1 |
| McGinity, M | 1 |
| Gilbert, A | 1 |
| Rossi, SA | 1 |
| de Oliveira, HC | 1 |
| Agreda-Mellon, D | 1 |
| Lucio, J | 1 |
| Mendes-Giannini, MJS | 1 |
| García-Cambero, JP | 1 |
| Zaragoza, O | 1 |
| Cunha Pereira, T | 2 |
| Rb-Silva, R | 2 |
| Félix Soares, R | 2 |
| Domingues, N | 2 |
| Mariz, J | 2 |
| Yi, P | 1 |
| Yang, X | 1 |
| Yang, M | 1 |
| Zhang, Y | 1 |
| Li, L | 1 |
| Claustre, J | 1 |
| Brion, JP | 1 |
| Quétant, S | 1 |
| Bedouch, P | 1 |
| Pison, C | 1 |
| Camara, B | 1 |
| Araujo Ribeiro, M | 1 |
| Alastruey-Izquierdo, A | 1 |
| Gomez-Lopez, A | 1 |
| Rodriguez-Tudela, JL | 1 |
| Cuenca-Estrella, M | 1 |
| Kontoyiannis, DP | 1 |
| Mehrany, K | 1 |
| Kist, JM | 1 |
| Gibson, LE | 1 |
| Polak, A | 1 |
| Kendirli, T | 1 |
| Ciftçi, E | 1 |
| Ince, E | 1 |
| Oncel, S | 1 |
| Dalgiç, N | 1 |
| Güriz, H | 1 |
| Unal, E | 1 |
| Dogru, U | 1 |
| Cancelli, I | 1 |
| Merlino, G | 1 |
| Serafini, A | 1 |
| Valente, M | 1 |
| Gigli, GL | 1 |
| Choi, JD | 1 |
| Powers, CJ | 1 |
| Vredenburgh, JJ | 1 |
| Friedman, AH | 1 |
| Sampson, JH | 1 |
| Denning, DW | 1 |
| Donnet, A | 1 |
| Graziani, N | 1 |
| Harlé, JR | 1 |
| Durand, JM | 1 |
| Touta, A | 1 |
| Grisoli, F | 1 |
| St Georgiev, V | 1 |
| Akiba, Y | 1 |
| Osanai, S | 1 |
| Nakano, H | 1 |
| Matsumoto, H | 1 |
| Onodera, S | 1 |
| Sato, M | 1 |
| Saku, N | 1 |
| Takeda, A | 1 |
| Suzuki, N | 1 |
| Saito, T | 1 |
| Minato, N | 1 |
| Saito, K | 1 |
| Kano, S | 1 |
| Benard, G | 1 |
| Gryschek, RC | 1 |
| Duarte, AJ | 1 |
| Shikanai-Yasuda, MA | 1 |
| Rex, JH | 1 |
| Walsh, TJ | 1 |
| Anaissie, EJ | 1 |
| Melzer, M | 1 |
| Colbridge, M | 1 |
| Keenan, F | 1 |
| Stainsby, D | 1 |
| Ong, EL | 1 |
| Tang, D | 1 |
| Wang, W | 1 |
| Fouassier, M | 1 |
| Joly, D | 1 |
| Cambon, M | 1 |
| Peigue-Lafeuille, H | 1 |
| Condat, P | 1 |
| Cawley, MJ | 1 |
| Braxton, GR | 1 |
| Haith, LR | 1 |
| Reilly, KJ | 1 |
| Guilday, RE | 1 |
| Patton, ML | 1 |
| Ellepola, AN | 1 |
| Samaranayake, LP | 1 |
| de Gans, J | 1 |
| Portegies, P | 1 |
| Tiessens, G | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| van Boxtel, CJ | 1 |
| van Ketel, RJ | 1 |
| Stam, J | 1 |
| Eloy, O | 1 |
| Joly, V | 1 |
| Ghnassia, JC | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| Sudduth, EJ | 1 |
| Crumbley, AJ | 1 |
| Farrar, WE | 1 |
| Polo, JM | 1 |
| Fábrega, E | 1 |
| Casafont, F | 1 |
| Fariñas, MC | 1 |
| Salesa, R | 1 |
| Vázquez, A | 1 |
| Berciano, J | 1 |
| Pedrol, E | 1 |
| Mallolas, J | 1 |
| González-Clemente, JM | 1 |
| Miró, JM | 1 |
| Azón, A | 1 |
| Gatell, JM | 1 |
| Moreno, A | 1 |
| Mensa, J | 1 |
| Soriano, E | 1 |
| White, M | 1 |
| Cirrincione, C | 1 |
| Blevins, A | 1 |
| Armstrong, D | 1 |
| Gazapo Carretero, E | 1 |
| García Aguado, C | 1 |
| Adrados de Llano, M | 1 |
| Martínez Blanco, ML | 1 |
| Verdejo Ortes, J | 1 |
| González Lahoz, JM | 1 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Maloisel, F | 1 |
| Dufour, P | 1 |
| Waller, J | 1 |
| Herbrecht, R | 1 |
| Marcellin, L | 1 |
| Koenig, H | 1 |
| Liu, KL | 1 |
| Weber, JC | 1 |
| Bergerat, JP | 1 |
| Oberling, F | 1 |
| Larsen, RA | 1 |
| Leal, MA | 1 |
| Chan, LS | 1 |
| ter Borg, F | 1 |
| Kuijper, EJ | 1 |
| van der Lelie, H | 1 |
| Surmont, I | 1 |
| Vergauwen, B | 1 |
| Marcelis, L | 1 |
| Verbist, L | 1 |
| Verhoef, G | 1 |
| Boogaerts, M | 1 |
| Kofler, H | 1 |
| Fritsch, P | 1 |
| Radentz, WH | 1 |
| Ray, TL | 1 |
| Weinke, T | 1 |
| Rögler, G | 1 |
| Sixt, C | 1 |
| de Matos-Marques, B | 1 |
| Pohle, HD | 1 |
| Staib, F | 1 |
| Seibold, M | 1 |
| Merz, WG | 1 |
| Karp, JE | 1 |
| Hoagland, M | 1 |
| Jett-Goheen, M | 1 |
| Junkins, JM | 1 |
| Hood, AF | 1 |
| Orefice, G | 1 |
| Carrieri, PB | 1 |
| Vecchione, V | 1 |
| Chirianni, A | 1 |
| Tullio-Cataldo, P | 1 |
| Striano, S | 1 |
| Bhansali, S | 1 |
| Karanes, C | 1 |
| Palutke, W | 1 |
| Crane, L | 1 |
| Kiel, R | 1 |
| Ratanatharathorn, V | 1 |
| Desai, MH | 1 |
| Herndon, DN | 1 |
| Abston, S | 1 |
| Flynn, P | 1 |
| Feldman, S | 1 |
| Lenoir, A | 1 |
| Pearson, T | 1 |
| Johnson, FL | 1 |
| Etcubanas, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis[NCT03569904] | 30 participants (Anticipated) | Observational | 2018-10-02 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 reviews available for flucytosine and Opportunistic Infections
| Article | Year |
|---|---|
Invasive mycoses: strategies for effective management.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Asparta | 2012 |
[Flucytosine - a classical partner for combination therapy].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Mitosporic Fungi; | 2002 |
Treatment of invasive aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Aspergillosis; Cholesterol Esters; Drug Carri | 1994 |
[Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients].
Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Brain Abscess; Brain Diseases; Cryptococcosis | 1993 |
Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis.
Topics: Amphotericin B; Animals; Cross Infection; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Com | 1993 |
[A case report--pulmonary cryptococcosis associated with systemic lupus erythematosus and review of 44 cases in Japan].
Topics: Arthritis, Rheumatoid; Cryptococcosis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; | 1993 |
Fungal infections in iatrogenically compromised hosts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Catheters, Indwelling; Diagno | 1998 |
[Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature].
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Combinations; Fatal Ou | 1998 |
Trichosporon beigelii infection: experience in a regional burn center.
Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial; | 2000 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agen | 2000 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th | 1992 |
Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans.
Topics: Adult; Amphotericin B; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combin | 1992 |
Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review.
Topics: Adult; Amphotericin B; Anemia, Aplastic; Flucytosine; Humans; Immunocompromised Host; Lung Diseases, | 1991 |
Cryptococcosis in the immunocompromised host.
Topics: Amphotericin B; Cryptococcosis; Flucytosine; Humans; Immunologic Deficiency Syndromes; Male; Middle | 1989 |
Opportunistic fungal infections in immunocompromised hosts.
Topics: Amphotericin B; Dermatomycoses; Flucytosine; Humans; Immunosuppression Therapy; Ketoconazole; Opport | 1989 |
Systemic candidiasis.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportu | 1989 |
Diagnosis and successful treatment of fusariosis in the compromised host.
Topics: Adult; Amphotericin B; Female; Flucytosine; Fusarium; Humans; Immune Tolerance; Leukemia; Leukemia, | 1988 |
2 trials available for flucytosine and Opportunistic Infections
| Article | Year |
|---|---|
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 1992 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1990 |
28 other studies available for flucytosine and Opportunistic Infections
| Article | Year |
|---|---|
Intracranial Epstein-Barr virus-associated smooth muscle tumor with superimposed cryptococcal infection: A case report.
Topics: Adult; Amphotericin B; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Epstein-Barr | 2022 |
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Topics: Amphotericin B; Animals; Antifungal Agents; Auranofin; Candida albicans; Candidiasis; Cell Line; Cic | 2020 |
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc | 2020 |
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc | 2020 |
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc | 2020 |
Case Report: Cryptococcal meningitis in Hodgkin's Lymphoma patient receiving brentuximab-vedotin therapy.
Topics: Amphotericin B; Antifungal Agents; Brentuximab Vedotin; Cryptococcus neoformans; Dexamethasone; Fluc | 2020 |
Multifocal muscle candidiasis of the legs in a patient with acute myeloid leukemia: A case report.
Topics: Abscess; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candida tropicalis; Candidiasis; | 2019 |
Favorable Evolution of Cryptococcal Meningitis in the Context of Flucytosine Resistance.
Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Substitution; Female; Fluc | 2018 |
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; | 2008 |
Cryptococcal infection in sarcoidosis.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Flucytosine; Humans; Mal | 2002 |
Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Male; | 2006 |
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fatal Outcome; Flucytosine; Human | 2008 |
Cryptococcal meningitis in patients with glioma: a report of two cases.
Topics: Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Alk | 2008 |
Successful antifungal treatment of disseminated candidiasis associated with ARDS.
Topics: Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Middle Aged; Oppor | 1993 |
Cryptococcosis as an opportunistic infection in immunodeficiency secondary to paracoccidioidomycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Flucytosine; Humans; Immunologic Deficienc | 1996 |
Cryptococcosis: an unusual opportunistic infection complicating B cell lymphoproliferative disorders.
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Female; Flucytos | 1998 |
Successful cure of an extensive burn injury complicated with mucor wound sepsis.
Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Body Surface Area; Burns; Debridemen | 1998 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1992 |
Treatment of cerebral aspergillosis after liver transplantation.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Brain Diseases; Combined Modality Therapy; Flu | 1992 |
[Cryptococcosis: presentation of 26 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Amphotericin B; Antigens, Fungal | 1992 |
Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1992 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug T | 1991 |
Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia.
Topics: Adult; Agranulocytosis; Amphotericin B; Appendix; Cecal Diseases; Female; Flucytosine; Humans; Injec | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Hu | 1990 |
Cryptococcosis in AIDS patients: observations concerning CNS involvement.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Male | 1989 |
Cryptococcal meningitis in AIDS patients. A two-case report.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Cryptococcosis; Drug Therapy, | 1988 |
Drugs for treatment of deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Op | 1988 |
Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement.
Topics: Adult; Amphotericin B; Combined Modality Therapy; Flucytosine; Humans; Leukemia, Monocytic, Acute; M | 1986 |
Candida infection in massively burned patients.
Topics: Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Burns; Candidiasis; Child; Flucytosine; | 1987 |
Torulopsis glabrata infection in immunocompromised children.
Topics: Amphotericin B; Candidiasis; Child; Child, Preschool; Drug Therapy, Combination; Female; Flucytosine | 1987 |